A randomized, multicenter, double-blind, parallel group study to compare the effects of bifeprunox and quetiapine on weight changes in stable schizophrenic patients.

Trial Profile

A randomized, multicenter, double-blind, parallel group study to compare the effects of bifeprunox and quetiapine on weight changes in stable schizophrenic patients.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 01 Jun 2011

At a glance

  • Drugs Bifeprunox; Quetiapine
  • Indications Schizophrenia
  • Focus Pharmacodynamics
  • Sponsors Abbott Healthcare Products
  • Most Recent Events

    • 20 Apr 2010 Actual patient number (83) added as reported by ClinicalTrials.gov.
    • 29 Jan 2008 Status change from recruiting to suspended.
    • 24 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top